Editas Medicine

Pharmaceuticals & Biotech

Editas Medicine Careers, Pay and Expert Network

lightbulbWhat are the highest paying jobs at Editas Medicine?

Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. The company went public on 2 Feb 2016. This initial public offering was noted as being the first such from a company which aims to use "DNA itself to internally treat afflictions". The company has conceded that “It will be many years, if ever, before we have a product candidate ready for commercialization.” Further, the companys valuation depends on a single patent, which holder was in dispute as of early 2016, presenting a major risk to the companys continued viability. The company entered into a strategic collaboration with Juno Therapeutics in 2015 to combine its CRISPR-Cas9 technology with Junos experience in creating chimeric antigen receptor and high-affinity T cell receptor therapeutics to the end of developing cancer therapeutics. The company announced in 2015 that it was planning a clinical trial in 2017 using CRISPR gene editing techniques to treat Lebers congenital amaurosis, a rare genetic illness that causes blindness.

Highest paying job titles at Editas Medicine include Clinical Director, Director of Regulatory Affairs, and Scientist


Market Cap$1.4 billion
Revenue$17.1 million
5 Year Trend+50.3%
Net Income-$127 million
Annual Report
Total value of jobs:
Total Jobs:
Average Pay:
Total Experts:
% Masters:

Top Experts at Editas Medicine

Editas Medicine Salaries

Clinical Director



Average Salary:$165,000

Director of Regulatory Affairs



Average Salary:$175,000




Average Salary:$90,000

Senior Scientist



Average Salary:$125,000

View All Salaries